Right ventricular targeted gene transfer of a β-adrenergic receptor kinase inhibitor improves ventricular performance after pulmonary artery banding

Journal of Thoracic and Cardiovascular Surgery

Volumn 127, Issue 3, 2004, Pages 787-793

  Emani, Sitaram M ^a   Shah, Ashish S ^a   Bowman, Michael K ^a   White, David C ^a   Emani, Sitaramesh ^a   Glower, Donald D ^a   Koch, Walter J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; BETA ADRENERGIC RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC RECEPTOR KINASE INHIBITOR GENE; BETA GALACTOSIDASE GENE; CHEMICAL ANALYSIS; CONTROLLED STUDY; GENE; GENE EXPRESSION; GENE TRANSFER; HEART AFTERLOAD; HEART DILATATION; HEART MUSCLE CONTRACTILITY; HEART RIGHT VENTRICLE; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE HYPERTROPHY; HEART TRANSPLANTATION; HEART VENTRICLE PERFORMANCE; HEART VENTRICLE REMODELING; LUNG ARTERY BANDING; NONHUMAN; PRIORITY JOURNAL; RABBIT; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; TRANSGENE;

EID: 1542374000     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5223(03)01189-9     Document Type: Article

References (22)

1. Hosenpud JD, Bennet LE, Keck BM, et al. The Registry of the International Society for Heart and Lung Transplantation: fifteenth official report 1998. J Heart Lung Transplant. 1998;17:656-68.
2. Warnecke I, Bein G, Bucherl ES. The relevance of intraoperative pressure and oxygen saturation monitoring during pulmonary artery banding in infancy. J Cardiothorac Anesth. 1989;3:31-6.
3. Kaul TK, Fields BL. Postoperative acute refractory right ventricular failure: incidence, pathogenesis, management and prognosis. Cardiovasc Surg. 2000;8:1-9.
4. Chen JM, Levin HR, Rose EA, et al. Experience with right ventricular assist devices for perioperative right sided circulatory failure. Ann Thorac Surg. 1996;61:305-10.
5. Hsieh CM, Mishkel GJ, Cardoso PF, et al. Production and reversibility of right ventricular hypertrophy and right heart failure in dogs. Ann Thorac Surg. 1992;54:104-10.
6. Welham KC, Silove ED, Wyse RK. Experimental right ventricular hypertrophy and failure in swine. Cardiovasc Res. 1978;12:61-5.
7. Bohm M, Flesch M, Schnabel P. Beta-adrenergic signal transduction in the failing and hypertrophied myocardium. J Mol Med. 1997;75: 842-8.
8. Arderson KM, Eckhart AD, Willette RN, Koch WJ. The myocardial β-adrenergic system in spontaneously hypertensive heart failure (SHHF) rats. Hypertension. 1999;33:402-7.
9. Choi DJ, Koch WJ, Hunter JJ, Rockman HA. Mechanism of β-adrenergic receptor desensitization in cardiac hypertrophy is increased β-adrenergic receptor kinase. J Biol Chem. 1997;272:17223-9.
10. Shah AS, Atkins BZ, Hata JA, et al. Early effects of right ventricular volume overload on ventricular performance and β-adrenergic signaling. J Thorac Cardiovasc Surg. 2000;120:342-9.
11. Rockman HA, Koch WJ, Lefkowitz RJ. Seven membrane spanning receptors and heart function. Nature. 2002;415:206-12.
12. Koch WJ, Rockman HA, Samama P, et al. Cardiac function in mice overexpressing the β-adrenergic receptor kinase or a βARK inhibitor. Science. 1995;268:1350-3.
13. Rockman HA, Chien KR, Choi D-J, et al. Expression of a β-adrenergic receptor kinase 1 inhibitor prevents the development of heart failure in gene targeted mice. Proc Natl Acad Sci U S A. 1998;95:7000-5.
14. Harding V, Jones L, Lefkowitz RJ, et al. Cardiac βARK1 inhibition prolongs survival and augments β blocker therapy in a mouse model of severe heart failure. Proc Natl Acad Sci U S A. 2001;98:5809-14.
15. Freeman K, Olsson MC, Iaccarino G, et al. Manipulation of cardiac adrenergic signaling and calcium cycling have markedly different effects on the progression of cardiomyopathy. J Clin Invest. 2001; 107: 967-74.
16. White DC, Hata JA, Shah AS, et al. Preservation of myocardial β-adrenergic receptor signaling delays the development of heart failure after myocardial infarction. Proc Natl Acad Sci U S A. 2000;97:5428-33.
17. Shah AS, White DC, Emani S, et al. In vivo ventricular gene delivery of a β-adrenergic receptor kinase inhibitor to the failing heart reverses cardiac dysfunction. Circulation. 2001;103:1311-6.
18. Hehir KM, Armentano D, Cardoza LM, et al. Molecular characterization of replication-competent variant of adenovirus vectors and genome modifications to prevent their occurrence. J Virol. 1996;70: 8459-67.
19. Shah AS, Lilly RE, Kypson AP, et al. Intracoronary adenovirus-mediated delivery and overexpression of the β2-adrenergic receptor in the heart: prospects for molecular ventricular assistance. Circulation. 2000;101:408-14.
20. Iaccarino G, Tomhave ED, Lefkowitz RJ, Koch WJ. Reciprocal in vivo regulation of myocardial G protein-coupled receptor kinase expression by β-adrenergic receptor stimulation and blockade. Circulation. 1998;98:1783-9.
21. Francis GS. Changing the remodeling process in heart failure: basic mechanisms and laboratory results. Curr Opin Cardiol. 1998;13:156-61.
22. Woodiwiss AJ, Tsotetsi OJ, Sprott S, et al. Reduction in myocardial collagen cross-linking parallels left ventricular dilatation in rat models of systolic chamber dysfunction. Circulation. 2001;103:155-60.